Patel Sanjiv, PRES, reported an open-market or private sale at Relay Therapeutics, Inc. involving 125000.000000 shares for an estimated $597500.00. Reported holdings after the transaction were 199548.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
President and CEO
These shares were sold by the Patel Family Irrevocable Trust of 2019 (the "Trust") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024.
This transaction was executed in multiple trades at prices ranging from $4.35 to $4.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to pro…
These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of thes…
This transaction was executed in multiple trades at prices ranging from $4.65 to $4.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to pro…
This transaction was executed in multiple trades at prices ranging from $4.62 to $4.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to pro…
Includes 762,360 shares underlying restricted stock units.
These shares are held in an irrevocable trust for the benefit of the reporting person's family members. An independent trustee is trustee of the trust. The reporting person disclaims beneficial owners…
0 other filings
0 recent txs